SummaryThe Centers for Medicare & Medicaid Services (CMS) is currently reviewing a new payment rule, which could impact coverage of innovative procedures like transcatheter aortic valve replacement for the treatment of severe aortic stenosis.
At the same time, a recent study published in The New England Journal of Medicine has shown that transcatheter aortic valve replacement (TAVR) is safer and more effective than older ways of treating patients with open-heart surgery. Coverage decisions for TAVR and other breakthrough medical technologies were made under 2012 guidance, which tightly governed which physicians may utilize it.
In my latest Forbes article, I discuss the considerations that CMS may want to take when it comes to payment decisions for innovative treatments like TAVR.
To receive more Avalere updates, connect with us.
produces measurable results. Let's work together.